oxazoles has been researched along with Leukemia, Myeloid, Acute in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazinet, A; Bhalla, K; Borthakur, G; Curry, JL; Daver, N; Heberton, M; Kadia, T; Khoury, JD; Kim, K; Konopleva, M; Loghavi, S; Miller, D; Pemmaraju, N; Pierce, S; Wilson, NR | 1 |
| Alcitepe, İ; Karatekin, İ; Kaymaz, BT; Salcin, H | 1 |
| Ahn, J; Choi, HK; Hwang, SG; Jalde, SS; Kim, HJ; Ryu, H; Song, JY | 1 |
| Bollag, G; Hernandez, D; Hizukuri, Y; Lee, L; Levis, M; Ma, Y; Narahara, M; Powell, B; Rajkhowa, T; Severson, P; Sumi, H; Zhang, C | 1 |
| Baccelli, I; Bertomeu, T; Blouin-Chagnon, V; Boivin, I; Bordeleau, ME; Boucher, G; Corneau, S; Coulombe-Huntington, J; Frechette, M; Gareau, Y; Gingras, S; Girard, S; Hébert, J; Kanshin, E; Krosl, J; Lavallée, VP; Lehnertz, B; Lemieux, S; Leveillé, K; MacRae, T; Marinier, A; Mayotte, N; Roux, PP; Sauvageau, G; Spinella, JF; St-Denis, C; Thibault, P; Thiollier, C; Tyers, M | 1 |
| Jin, Y; Liu, H; Meng, H; Qian, W; Yang, C; Yang, X; You, L | 1 |
| Burnett, AK; Lazenby, M; Pepper, C; Walsby, E | 1 |
| Chandrasekar, PH; Clark, NM; Kauffman, CA; McNeil, SA | 1 |
| Chitneni, SR; Moore, JO; Nichols, KE; Weinberg, JB | 1 |
| Capizzi, RL; Craig, JB; Powell, BL; Richards, F | 1 |
10 other study(ies) available for oxazoles and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine.
Topics: Azacitidine; Humans; Leukemia; Leukemia, Myeloid, Acute; Oxazoles; Pyridines; Pyrroles; Skin Neoplasms | 2022 |
HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents' combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Oxazoles; Pyridines; Pyrroles; Vorinostat | 2022 |
Discovery of Oxazol-2-amine Derivatives as Potent Novel FLT3 Inhibitors.
Topics: Amines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; DNA Repair; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Mutation; Neoplasm Transplantation; Oxazoles; Poly (ADP-Ribose) Polymerase-1; Protein Kinase Inhibitors | 2020 |
A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia.
Topics: Animals; Apoptosis; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mice; Mutation; Oxazoles; Protein Kinase Inhibitors; Pyridines; Pyrroles; Tumor Microenvironment | 2021 |
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Complex I; Female; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Mice; Models, Biological; Oxazoles; Oxidative Phosphorylation; Protein Kinase Inhibitors; Receptor, ErbB-2; Triazoles | 2019 |
SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Proliferation; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Oxazoles; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2013 |
The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Cell Cycle; Cells, Cultured; Cyclin-Dependent Kinases; Cytarabine; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Oxazoles; Phosphorylation; Thiazoles | 2011 |
Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Oxazoles; Oxazolidinones; Postoperative Complications; Treatment Failure; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2000 |
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
Topics: Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Isoxazoles; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Leukocytes; Oxazoles; Reference Values; Tumor Cells, Cultured | 1989 |
Phase I-II trial of acivicin in adult acute leukemia.
Topics: Aged; Antibiotics, Antineoplastic; Drug Evaluation; Humans; Isoxazoles; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Oxazoles | 1988 |